Related Experiment Video
Updated: Apr 17, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Familial Mediterranean Fever
Adem Kucuk1, Ilknur Albayrak Gezer2, Ramazan Ucar3
1Necmettin Erbakan Üniversitesi Romatoloji Bilim Dalı Konya,Turkey.
Abstract:
Familial Mediterranean Fever is an autosomal recessive inherited disease with a course of autoinflammation, which is characterized by the episodes of fever and serositis. It affects the populations from Mediterranean basin. Genetic mutation of the disease is on MEFV gene located on short arm of Chromosome 16. The disease is diagnosed based on clinical evaluation. Amyloidosis is the most important complication. The only agent that decreases the development of amyloidosis and the frequency and severity of the episodes is colchicine, which has been used for about 40 years. In this review, we aimed to discuss especially the most recent advances about Familial Mediterranean Fever which is commonly seen in our population.
Insights
Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disorder causing fever and serositis. Colchicine remains the primary treatment to prevent complications like amyloidosis and reduce FMF episode severity.
Area of Science:
- Genetics
- Immunology
- Internal Medicine
Background:
- Familial Mediterranean Fever (FMF) is an autosomal recessive autoinflammatory disease prevalent in Mediterranean populations.
- Characterized by recurrent episodes of fever and serositis, FMF is linked to mutations in the MEFV gene on chromosome 16.
- Amyloidosis is a significant complication, and colchicine has been the mainstay treatment for decades.
Purpose of the Study:
- To review recent advancements in understanding and managing Familial Mediterranean Fever.
- To highlight the current therapeutic strategies and their impact on disease progression.
Main Methods:
- Literature review focusing on recent research and clinical findings related to FMF.
- Analysis of genetic mutations, diagnostic criteria, and treatment outcomes.
Main Results:
- Colchicine effectively reduces the frequency and severity of FMF episodes and prevents amyloidosis.
- Ongoing research explores novel therapeutic targets and personalized treatment approaches.
Conclusions:
- Familial Mediterranean Fever requires long-term management, primarily with colchicine.
- Continued research is crucial for improving patient outcomes and exploring alternative therapies for FMF.
More Related Videos
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Types of Fever
Here are the different types of fever:
Patterns of Fever
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Myocarditis II: Clinical Features and Diagnostic Tests
Increased Body Temperature
Myocarditis I: Introduction